For those aiming to surpass market returns, the art of stock picking is crucial. Making wise choices in stocks can greatly enhance your overall wealth.
ImmunityBio Inc (NASDAQ: IBRX) closed the day trading at $2.07 down -0.96% from the previous closing price of $2.09. In other words, the price has decreased by -$0.96 from its previous closing price. On the day, 6.51 million shares were traded.
Ratios:
For a better understanding of IBRX, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 3.21 and its Current Ratio is at 3.36.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, H.C. Wainwright on March 06, 2025, initiated with a Buy rating and assigned the stock a target price of $8.
On January 10, 2025, BTIG Research started tracking the stock assigning a Buy rating and target price of $6.
Piper Sandler Downgraded its Overweight to Neutral on May 12, 2023, whereas the target price for the stock was revised from $10 to $4.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 123.94.
Stock Price History:
Over the past 52 weeks, IBRX has reached a high of $9.16, while it has fallen to a 52-week low of $1.83. The 50-Day Moving Average of the stock is -23.71%, while the 200-Day Moving Average is calculated to be -42.16%.
Shares Statistics:
A total of 852.74M shares are outstanding, with a floating share count of 91.81M. Insiders hold about 89.60% of the company’s shares, while institutions hold 9.78% stake in the company.
